SCHEMBL23200538

SCHEMBL23200538

NS(=O)(=O)c1ccc(C=O)cc1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CA2 P00918 6/20 0.41
CA12 O43570 3/20 0.41
CA1 P00915 3/20 0.41
CA9 Q16790 2/20 0.41
PTGS2 P35354 2/20 0.41
KDM4E B2RXH2 1/20 0.41
RAB9A P51151 1/20 0.41
STS P08842 1/20 0.40
PTGES2 Q9H7Z7 5/20 0.38
PTGS1 P23219 1/20 0.38
TET2 Q6N021 1/20 0.37
CA7 P43166 2/20 0.36
CA13 Q8N1Q1 1/20 0.36
CA4 P22748 1/20 0.36
CA6 P23280 1/20 0.36
CA5A P35218 1/20 0.36
CA14 Q9ULX7 1/20 0.36
CA5B Q9Y2D0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24670015 0.85 CA12 (0.41) ALDH1A1SMN1; SMN2CA2CA12CA1
SCHEMBL48553 0.81 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2CA2CA12CA1
SCHEMBL29399275 0.81 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2CA2CA12CA1
SCHEMBL15574149 0.78 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2CA2PTGS2KDM4E
SCHEMBL13044803 0.77 ALDH1A1 (0.55) ALDH1A1CA2CA12CA1CA9
SCHEMBL31727287 0.77 PDIA6 (0.49) ALDH1A1CA2CA12CA1CA9
Formic Acid SCHEMBL14247448 0.76 PTGES2 (0.43) CA2CA12CA1CA9PTGS2
SCHEMBL29556118 0.75 PTGS1 (0.48) ALDH1A1CA2CA12CA1CA9
SCHEMBL789994 0.75 PTGS1 (0.48) ALDH1A1CA2CA12CA1CA9
SCHEMBL1465117 0.75 HTR2A (0.45) ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12173018-B2 Penicillin-binding protein inhibitors VenatoRx Pharmaceuticals, Inc. (US) 2024-12-24 US disclosed
US-20210198288-A1 PENICILLIN-BINDING PROTEIN INHIBITORS VenatoRx Pharmaceuticals, Inc. 2021-07-01 US disclosed
EP-3802551-A1 PENICILLIN-BINDING PROTEIN INHIBITORS Venatorx Pharmaceuticals, Inc. (US) 2021-04-14 EP disclosed
CN-112469725-A Penicillin binding protein inhibitors 维纳拓尔斯制药公司 2021-03-09 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210198288-A1 PENICILLIN-BINDING PROTEIN INHIBITORS PEPD, BPGM, EBPL ALDH1A1 2794/4885SMN1; SMN2 3101/4885CA2 2155/4885
US-12173018-B2 Penicillin-binding protein inhibitors PEPD, BPGM, EBPL ALDH1A1 2794/4885SMN1; SMN2 3101/4885CA2 2155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.